Cargando…

Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism

Mitochondrial isocitrate dehydrogenase 2 (IDH2) is an important metabolic enzyme in the tricarboxylic acid cycle (TCA) cycle. Our previous study showed that high expression of wild-type IDH2 promotes the proliferation of lung cancer cells. This study aims to test the potential of targeting IDH2 as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, He, Li, Jiang-jiang, Lu, Wenhua, Yang, Jing, Xia, Yunfei, Huang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953680/ https://www.ncbi.nlm.nih.gov/pubmed/36831011 http://dx.doi.org/10.3390/biomedicines11020475

Ejemplares similares

Cyanidin ameliorates cisplatin-induced cardiotoxicity via inhibition of ROS-mediated apoptosis
por: Qian, Peng, et al.
Publicado: (2018)

Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2
por: Park, Bong Hee, et al.
Publicado: (2016)

Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression
por: Zhang, Wendian, et al.
Publicado: (2016)

Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-γ in colon cancer
por: Tai, YunYan, et al.
Publicado: (2018)

GSDME enhances Cisplatin sensitivity to regress non-small cell lung carcinoma by mediating pyroptosis to trigger antitumor immunocyte infiltration
por: Peng, Zhouyangfan, et al.
Publicado: (2020)

Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma
por: Liu, Yufeng, et al.
Publicado: (2020)

Dichloroacetate enhances the antitumor effect of pirarubicin via regulating the ROS-JNK signaling pathway in liver cancer cells
por: Yan, Xiao-Jing, et al.
Publicado: (2020)

Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROS
por: Pan, Xiaobo, et al.
Publicado: (2022)

Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding
por: Peng, Huifang, et al.
Publicado: (2017)

Akkermansia muciniphila Enhances the Antitumor Effect of Cisplatin in Lewis Lung Cancer Mice
por: Chen, Zhuo, et al.
Publicado: (2020)

Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis
por: Liu, Liang, et al.
Publicado: (2021)

Potent USP10/13 antagonist spautin‐1 suppresses melanoma growth via ROS‐mediated DNA damage and exhibits synergy with cisplatin
por: Guo, Jia, et al.
Publicado: (2020)

IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity
por: Khurshed, Mohammed, et al.
Publicado: (2018)

Calycosin Alleviates Sepsis-Induced Acute Lung Injury via the Inhibition of Mitochondrial ROS-Mediated Inflammasome Activation
por: Xia, Yu, et al.
Publicado: (2021)

Panax notoginseng saponins ameliorate cisplatin‐induced mitochondrial injury via the HIF‐1α/mitochondria/ROS pathway
por: Li, Qingqing, et al.
Publicado: (2019)

Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
por: Wangpaichitr, Medhi, et al.
Publicado: (2017)

Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma
por: Lin, Lin, et al.
Publicado: (2021)

Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc
por: Zuo, Yufang, et al.
Publicado: (2018)

Depletion of tumor‐associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin
por: Kawaguchi, Yo, et al.
Publicado: (2022)

Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS
por: Qu, Xianzhi, et al.
Publicado: (2017)

Biocompatible Nanoparticles as a Platform for Enhancing Antitumor Efficacy of Cisplatin–Tetradrine Combination
por: Liu, Fangcen, et al.
Publicado: (2021)

Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition
por: Yang, Li, et al.
Publicado: (2017)

IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution
por: Rodriguez, Erika F., et al.
Publicado: (2020)

Cisplatin Synergistically Enhances Antitumor Potency of Conditionally Replicating Adenovirus via p53 Dependent or Independent Pathways in Human Lung Carcinoma
por: Ali, Sakhawat, et al.
Publicado: (2019)

Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-Resistant Lung Cancer
por: Xin, Qian, et al.
Publicado: (2022)

Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation
por: Choi, Yong-Min, et al.
Publicado: (2015)

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia
por: Wang, Tao, et al.
Publicado: (2023)

Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
por: Marullo, Rossella, et al.
Publicado: (2013)

Curcumenol Targeting YWHAG Inhibits the Pentose Phosphate Pathway and Enhances Antitumor Effects of Cisplatin
por: Mao, Zhijie, et al.
Publicado: (2022)

Enhanced antitumor activity of realgar mediated by milling it to nanosize
por: Tian, Ye, et al.
Publicado: (2014)

Upconversion nanoparticle-mediated photodynamic therapy induces THP-1 macrophage apoptosis via ROS bursts and activation of the mitochondrial caspase pathway
por: Zhu, Xing, et al.
Publicado: (2015)

Melatonin Enhances Cisplatin and Radiation Cytotoxicity in Head and Neck Squamous Cell Carcinoma by Stimulating Mitochondrial ROS Generation, Apoptosis, and Autophagy
por: Fernandez-Gil, Beatriz I., et al.
Publicado: (2019)

Therapeutic potential of the mitochondria-targeted antioxidant MitoQ in mitochondrial-ROS induced sensorineural hearing loss caused by Idh2 deficiency
por: Kim, Ye-Ri, et al.
Publicado: (2018)

Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin
por: Comenge, Joan, et al.
Publicado: (2012)

Induction of Apoptosis by Costunolide in Bladder Cancer Cells is Mediated through ROS Generation and Mitochondrial Dysfunction
por: Rasul, Azhar, et al.
Publicado: (2013)

Mubritinib enhanced the inhibiting function of cisplatin in lung cancer by interfering with mitochondrial function
por: Dong, Jingyao, et al.
Publicado: (2022)

Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer
por: Chen, Weiqian, et al.
Publicado: (2016)

Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process
por: Su, Yu-Li, et al.
Publicado: (2023)

Piperlongumine Inhibits Akt Phosphorylation to Reverse Resistance to Cisplatin in Human Non-Small Cell Lung Cancer Cells via ROS Regulation
por: Zhang, Chao, et al.
Publicado: (2019)

A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products
por: Li, Keke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ffk3jkoa0nnn5c2o6s8ec8png8